Anesthesia Drugs Market Size, Share, Growth, Trends, and Industry Analysis: By Type (General Anesthesia, Regional Anesthesia, Local Anesthesia, and Others), By Drugs (General Anesthetics, Local Anesthetics, and Others), By Route of Administration (Inhalation, Intravenous, and Others), By End Users (Hospitals and Ambulatory Surgical Centres), and Region Forecast 2019-2030

Purchase Option

$ 4400
$ 6600
$ 8900

Anesthesia Drugs Market size was valued at USD 8,725.6 million in 2023 and is expected to grow at a CAGR of 3.8% from 2024 - 2030.  The anesthesia drug market is expanding due to some significant factors an increase in the prevalence of chronic diseases such as cancer, cardiovascular disease, and osteoarthritis; a rise in demand for inhalation anesthesia; an increase in funding from private & government organizations for the development of pharmaceutical manufacturing segments; and rise in R&D activities for the formulation of a general anesthesia drug. The rise in funding from public and private organizations for the development of pharmaceutical manufacturing segments; and the rise in research and development efforts for the formulation of general anesthesia drugs are the main factors driving the growth of the global market share for general anesthesia drugs.

Furthermore, the World Health Organization revealed in 2022 that the leading cause of mortality worldwide is cardiovascular disease. Individuals who suffer from atrial fibrillation, heart failure, or coronary heart disease are more likely to require open heart surgery. Under general anesthesia, open heart surgery is performed. This element fuels the market's expansion. The United States had severe shortages of essential anesthetic medications following the emergence of COVID-19, including dexmedetomidine, midazolam, propofol, and neuromuscular blocking medicines. As a result, a lot of businesses are producing more anesthetic medications.

For example, Hikma Pharmaceutical debuted "Propofol Injectable Emulsion," a new medicine, in the US market in May 2020. Emerging markets expansion, innovation in drug development, integration of advanced technologies, personalized medicine, expansion of ambulatory and outpatient surgery centers, strategic partnerships and collaborations, opioid-sparing strategies, regenerative medicine, and new techniques. Additionally, advances in technology in the delivery of Drugs, the development of specifically targeted medicines, the development of devices to monitor patient's physiological parameters during and after Anesthesia, and reduced side effects of anesthetics are the opportunities that will boost the market growth. 

Anesthesia Drugs Market Key Developments:

  • In January 2022, Laboratories Théa SAS (Théa) entered an agreement to purchase seven branded ophthalmic products from Akorn Operating Company LLC. The strategic move will enable Théa to add Akorn-branded products to its portfolio, including Akten (lidocaine HCl ophthalmic gel), a local anesthetic indicated for ocular surface anesthesia during ophthalmologic procedures.
  • In March 2021: Pacira BioSciences Inc.'s supplemental new drug application (sNDA) for the augmented use of Exparel (Bupivacaine Liposome Injectable Suspension) in pediatric patients was approved by the U.S. Food and Drug. 

Anesthesia Drugs Market Summary

Study Period

2024 - 2030

Base Year

2023

CAGR

3.8%

Largest Market

North America

Fastest Growing Market

Asia pacific

Anesthesia Drugs Market Dynamics

The anesthesia drug market's increasing number of surgeries, the aging population with an increase in chronic illnesses, and the developments in anesthetic technologies are further factors propelling this market. The American Society of Plastic Surgeons (ASPS) estimates that in 2020, 6.1 million cosmetic treatments were carried out on individuals between the ages of 40 and 54, and around 768,000 procedures were conducted on those between the ages of 10 and 29. These figures show that the number of surgeries performed in the area is steadily rising, which in turn is fueling the need for anesthetic medications. The market is anticipated to develop substantially as a result of the use of anesthetics in general operations. Thus, all aforementioned factors, such as the increasing number of surgical procedures and product launches, boost the market over the forecast period. The scarcity of healthcare facilities in developing nations and isolated locations, as well as the dearth of anesthesia physicians and certified anesthesia nurses per capita, is predicted to be a growth inhibitor for the anesthesia drugs market. High costs for procedures and branded drugs could hinder this market's expansion during the forecast period. Another factor hurting the market for anesthesia drugs is the general public's ignorance of anesthesia.

Anesthesia Drugs Market Segmentation

By Type

  • General Anesthesia
  • Regional Anesthesia
  • Local Anesthesia
  • Other

By Drugs

  • General Anesthetics
  • Local Anesthetics
  • Others

By Route of Administration

  • Engine
  • Flight Control System
  • Aerostructure
  • Landing Gear

By End Users

  • Hospitals
  • Ambulatory surgical center

Frequently Asked Questions

The anaesthesia drug market was valued at USD 8,725.6 million in 2023 and is expected to grow at a CAGR of 3.8% over the forecast period.

An increasing number of surgical procedures, a rising geriatric population, advances in anesthesia technology, a growing prevalence of chronic diseases, and an expanding healthcare infrastructure are the key drivers in the anesthesia drug market.

The prevalence of chronic illnesses like cancer, heart disease, and osteoarthritis is rising. In addition, there is a growing need for inhalation anesthesia. These are the main trends in the market for general anesthesia drugs.

Biomedical Research Models (Biomere), Transpogen Biopharmaceutical, Inc., Pfizer Inc., Heritage Pharmaceuticals Inc., Piramal Enterprises Limited, Sanofi Fresenius SE & Co, Novartis AG, AbbVie the key players in the anesthesia drugs market.

Asai-Pacific is the fastest-growing region in the anesthesia drug market.

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenarios.
1. Executive Summary
2. Global Anesthesia Drugs Market Introduction 
2.1.Global Anesthesia Drugs Market  - Taxonomy
2.2.Global Anesthesia Drugs Market  - Definitions
2.2.1.Type
2.2.2.Drugs
2.2.3.Route of Administration 
2.2.4.End Users
2.2.5.Region
3. Global Anesthesia Drugs Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Anesthesia Drugs Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Anesthesia Drugs Market  By Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. General Anesthesia
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Regional Anesthesia
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Local Anesthesia
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Other
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6. Global Anesthesia Drugs Market  By Drugs, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. General Anesthetics
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Local Anesthetics
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Others
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7. Global Anesthesia Drugs Market  By Route of Administration , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Engine
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Flight Control System
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Aerostructure
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Landing Gear
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8. Global Anesthesia Drugs Market  By End Users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Hospitals
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Ambulatory surgical center
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
9. Global Anesthesia Drugs Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10. North America Anesthesia Drugs Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.General Anesthesia
10.1.2.Regional Anesthesia
10.1.3.Local Anesthesia
10.1.4.Other
10.2.  Drugs Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.General Anesthetics
10.2.2.Local Anesthetics
10.2.3.Others
10.3.  Route of Administration  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Engine
10.3.2.Flight Control System
10.3.3.Aerostructure
10.3.4.Landing Gear
10.4.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Hospitals
10.4.2.Ambulatory surgical center
10.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11. Europe Anesthesia Drugs Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.General Anesthesia
11.1.2.Regional Anesthesia
11.1.3.Local Anesthesia
11.1.4.Other
11.2.  Drugs Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.General Anesthetics
11.2.2.Local Anesthetics
11.2.3.Others
11.3.  Route of Administration  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Engine
11.3.2.Flight Control System
11.3.3.Aerostructure
11.3.4.Landing Gear
11.4.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Hospitals
11.4.2.Ambulatory surgical center
11.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12. Asia Pacific (APAC) Anesthesia Drugs Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.General Anesthesia
12.1.2.Regional Anesthesia
12.1.3.Local Anesthesia
12.1.4.Other
12.2.  Drugs Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.General Anesthetics
12.2.2.Local Anesthetics
12.2.3.Others
12.3.  Route of Administration  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Engine
12.3.2.Flight Control System
12.3.3.Aerostructure
12.3.4.Landing Gear
12.4.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Hospitals
12.4.2.Ambulatory surgical center
12.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13. Middle East and Africa (MEA) Anesthesia Drugs Market,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.General Anesthesia
13.1.2.Regional Anesthesia
13.1.3.Local Anesthesia
13.1.4.Other
13.2.  Drugs Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.General Anesthetics
13.2.2.Local Anesthetics
13.2.3.Others
13.3.  Route of Administration  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Engine
13.3.2.Flight Control System
13.3.3.Aerostructure
13.3.4.Landing Gear
13.4.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Hospitals
13.4.2.Ambulatory surgical center
13.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14. Latin America Anesthesia Drugs Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.General Anesthesia
14.1.2.Regional Anesthesia
14.1.3.Local Anesthesia
14.1.4.Other
14.2.  Drugs Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.General Anesthetics
14.2.2.Local Anesthetics
14.2.3.Others
14.3.  Route of Administration  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Engine
14.3.2.Flight Control System
14.3.3.Aerostructure
14.3.4.Landing Gear
14.4.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Hospitals
14.4.2.Ambulatory surgical center
14.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Charles River Laboratories International, Inc.
15.2.2.The Jackson   Laboratory
15.2.3.Laboratory Corporation of America Holdings (Covance)
15.2.4.Perkin Elmer (Horizon Discovery Group plc)
15.2.5.Biomedical Research Models (Biomere)
15.2.6.Transpogen Biopharmaceutical, Inc.
15.2.7.Pfizer Inc
15.2.8.Heritage Pharmaceuticals Inc.
15.2.9.Piramal Enterprises Limited
15.2.10.Sanofi Fresenius SE & Co 
15.2.11.Novartis AG 
15.2.12.AbbVie
16. Research Methodology 
17. Appendix and Abbreviations 
  • Charles River Laboratories International, Inc.
  • The Jackson   Laboratory
  • Laboratory Corporation of America Holdings (Covance)
  • Perkin Elmer (Horizon Discovery Group plc)
  • Biomedical Research Models (Biomere)
  • Transpogen Biopharmaceutical, Inc.
  • Pfizer Inc
  • Heritage Pharmaceuticals Inc.
  • Piramal Enterprises Limited
  • Sanofi Fresenius SE & Co 
  • Novartis AG
  • AbbVie

Adjacent Markets